Pharmaceutical News

RSS

Breakthrough SARS-CoV-2 infection peaks at 5 months

A new study describes the incidence of breakthrough infection with SARS-CoV-2 after vaccination with one of the nucleic acid or viral vector vaccines.

28 Feb 2022

Updated guideline released for managing antirheumatic drugs in patients undergoing hip or knee replacement

The American College of Rheumatology and the American Association of Hip and Knee Surgeons released a summary of their updated guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.

28 Feb 2022

Outpatient antibiotic treatment for infective endocarditis improves outcomes, reduces costs

A new modeling study suggests that when patients who inject opioids continue an antibiotic treatment for infective endocarditis outside of the hospital, they experienced better long-term health outcomes than patients who receive the standard four to six weeks of inpatient, intravenous antibiotic therapy.

28 Feb 2022

Computer model warns about the negative consequences of diabetes treatment for some cancers

Using computer drug simulations, researchers have found that doctors need to be wary of prescribing a particular treatment for all types of cancer and patients.

28 Feb 2022

Antibiotics provide no benefit in preventing recurrent wheezing in infants hospitalized with RSV

Antibiotics provide no benefit in preventing future recurrent wheezing in babies hospitalized with respiratory syncytial virus (RSV), according to a new study led by Washington University School of Medicine in St. Louis. And there is some evidence that antibiotics may make wheezing worse.

27 Feb 2022

Study determines effectiveness of COVID-19 vaccination against Omicron variant in high-risk indoor settings

A new study estimates vaccine effectiveness against SARS-CoV-2 Omicron variant in indoor entertainment settings in Australia.

27 Feb 2022

A promising new vaccine for SARS-CoV-2 and influenza

Researchers create a vaccine candidate that could protect against both SARS-CoV-2 and IAVs.

27 Feb 2022

Traditional Chinese medicine can be an effective radiosensitizer for patients with nasopharyngeal carcinoma

Treatment of nasopharyngeal carcinoma (NPC), a group of cancers that originate in the nose and throat, is made complicated by their unique position. Radiation therapy is often the main curative treatment for NPC. However, some patients are resistant to radiation therapy.

25 Feb 2022

Serological responses to heterologous COVID-19 mRNA vaccination in older individuals

Researchers assess the serological response to a real-world COVID-19 vaccination strategy in older individuals who resided in long-term care facilities.

24 Feb 2022

A comparison of COVID-19 vaccines by neutralizing antibody potency

Researchers use an international standardized assessment method to compare the efficacy of antibody responses to the major COVID-19 vaccines.

24 Feb 2022

Study examines the effect of sevoflurane on sleep disturbance caused by systemic inflammation

Getting a good night's sleep can sometimes be a challenge, but inflammation may make it even more difficult.

24 Feb 2022

Nearly 1% of all US adults prescribed opioids are also taking various other sedatives

As many as 2.6 million Americans—equivalent to 1 per cent of all US adults —prescribed opioids are also taking various other sedatives, including benzodiazepines plus another type of sedative drug, estimates research published online in the journal Regional Anesthesia & Pain Medicine.

23 Feb 2022

Omicron neutralizing titers after third BNT162b2 dose are persistent

The new study, published in the journal Cell Host and Microbe, also finds that the neutralization against Omicron remains robust at four months after the third dose of the BNT162b2 vaccine.

22 Feb 2022

Study shows Pfizer-BioNTech booster protects over 65s against Delta and Omicron

New research in nursing home residents found that a third dose of the Pfizer-BioNTech COVID-19 vaccine was effective for at least three months in protecting against the Delta and Omicron variant. While two doses of an mRNA COVID-19 vaccine showed poor neutralization to Omicron than Delta, a booster shot increased neutralizing antibody responses.

22 Feb 2022

Novel ACE2-blocking antibody protects against all SARS-CoV-2 VOCs

Researchers identify 87G7, a SARS-CoV-2 neutralizing human monoclonal antibody with remarkable broad-spectrum neutralization and protection efficacy.

21 Feb 2022

Study reports potently neutralizing mucosal IgA in saliva of BNT162b2 vaccine recipients

researchers determine the strong neutralizing mucosal component emanating from intramuscular administration of an mRNA vaccine.

21 Feb 2022

Analysis reveals the truth about FDA's expedited approval processes and patient access

University of Illinois Chicago researchers studied 135 products that received U.S. Food and Drug Administration approval through orphan drug and expedited approval program designations.

21 Feb 2022

European research project focuses on fighting against new psychoactive drugs

Promoting the fight against the use of drugs of abuse, anticipating to the appearance of new psychoactive drugs and assessing the risks these have on human health are the main objectives of the European research project approved by the European Commission and led by the Research Group on Neuropsychopharmacology of Amphetamine Derivatives of the University of Barcelona.

21 Feb 2022

Expert highlights the racist origins of US drug policy and its effect on the modern opioid epidemic

In his work as a pain management pharmacist, Dan Arendt has seen some of his patients stigmatized as "drug seekers" or blamed for their use of opioids rather than being acknowledged as a person who is suffering from a severely painful condition.

21 Feb 2022

Full schedule of CoronaVac vaccine shown to be highly effective in children

A recent study on vaccine effectiveness showed that a complete primary immunization with CoronaVac effectively protects against severe coronavirus disease 2019 (COVID-19) for children and adolescents between 6 and 16 years of age – consistent with the results from phase 2 clinical trials. The paper is currently available on the Preprints with The Lancet* server while it undergoes peer review.

20 Feb 2022

Previous
1
...
86
87
88
89
90
91
92
...
1434
Next

Pharmaceutical News

Breakthrough SARS-CoV-2 infection peaks at 5 months

Updated guideline released for managing antirheumatic drugs in patients undergoing hip or knee replacement

Outpatient antibiotic treatment for infective endocarditis improves outcomes, reduces costs

Computer model warns about the negative consequences of diabetes treatment for some cancers

Antibiotics provide no benefit in preventing recurrent wheezing in infants hospitalized with RSV

Study determines effectiveness of COVID-19 vaccination against Omicron variant in high-risk indoor settings

A promising new vaccine for SARS-CoV-2 and influenza

Traditional Chinese medicine can be an effective radiosensitizer for patients with nasopharyngeal carcinoma

Serological responses to heterologous COVID-19 mRNA vaccination in older individuals

A comparison of COVID-19 vaccines by neutralizing antibody potency

Study examines the effect of sevoflurane on sleep disturbance caused by systemic inflammation

Nearly 1% of all US adults prescribed opioids are also taking various other sedatives

Omicron neutralizing titers after third BNT162b2 dose are persistent

Study shows Pfizer-BioNTech booster protects over 65s against Delta and Omicron

Novel ACE2-blocking antibody protects against all SARS-CoV-2 VOCs

Study reports potently neutralizing mucosal IgA in saliva of BNT162b2 vaccine recipients

Analysis reveals the truth about FDA's expedited approval processes and patient access

European research project focuses on fighting against new psychoactive drugs

Expert highlights the racist origins of US drug policy and its effect on the modern opioid epidemic

Full schedule of CoronaVac vaccine shown to be highly effective in children

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News